Form 4: NeueHealth CEO Sells Shares to Cover Tax Obligations After Vesting of Restricted Stock Units

NeueHealth CEO George Lawrence Mikan III sold 16,803 shares of common stock to cover tax obligations after the vesting of restricted stock units.

Summary

• NeueHealth CEO George Lawrence Mikan III exercised 35,000 restricted stock units on December 14, 2024.
• Following the vesting, Mr. Mikan sold 16,803 shares of common stock on December 17, 2024, at an average price of $4.18 per share.
• The sale was to cover tax withholding obligations related to the vesting of the restricted stock units.
• The shares were sold in multiple transactions at prices ranging from $3.99 to $4.60 per share.
• After these transactions, Mr. Mikan directly owns 83,029 shares of NeueHealth common stock.

Sentiment

Score: 5

Explanation: This is a routine transaction related to executive compensation and does not indicate any positive or negative sentiment about the company's performance.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a common practice across publicly traded companies.
• The sale of shares after vesting of restricted stock units is a standard part of executive compensation packages.
• Similar transactions are regularly reported by executives at companies like UnitedHealth Group, CVS Health, and Humana.

Stakeholder Impact

• The sale of shares by the CEO may have a minor impact on the stock price, but it is not expected to be significant.

Key Dates

Keywords

insider trading, stock sale, restricted stock units, tax obligations, executive compensation, Form 4, NeueHealth